Johannes Gutenberg-Universität Mainz
- 6131/39-0
Kohls, N.; Delle-Karth, G.; Fiedler, L. et al.
News in the treatment of acute pulmonary embolism four years after publication of the ESC guidelinesJOURNAL FUR KARDIOLOGIE. Bd. 31. H. 7-8. 2024
Huber, Yvonne; Huber, Tobias; Reichermeier, Stefanie et al.
NEXT GEN at Visceral Medicine 2024: A ReviewZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 62. H. 11. 2024 S. 1981-1982
Jankowiak, Sylvia; Rossnagel, Karin; Bauer, Juliane et al.
Night shift work and cardiovascular diseases among employees in Germany: five-year follow-up of the Gutenberg Health StudySCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH. Bd. 50. H. 3. 2024 S. 142-151
Schildknecht, Stefan; Daiber, Andreas
NITRIC OXIDE, SUPEROXIDE AND PEROXYNITRITE - REDOX REGULATION OF THE CARDIOVASCULAR SYSTEM BY NITRO-OXIDATIVE STRESS AND S-NITROS(YL)ATIONFREE RADICAL BIOLOGY AND MEDICINE. Bd. 218. 2024 S. 32-32
Moehler, Markus; Janjigian, Yelena Y.; Shitara, Kohei et al.
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 3-year follow-up from CheckMateONCOLOGY RESEARCH AND TREATMENT. Bd. 47. 2024 S. 64-64
Shitara, Kohei; Moehler, Markus H.; Ajani, Jaffer A. et al.
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 4 year (yr) follow-up of CheckMate 649.JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 3_SUPPL. 2024 S. 306-306
Elimova, Elena; Shitara, Kohei; Moehler, Markus H. et al.
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 4-year follow-up of CheckMate 649JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 16. 2024
Galle, Peter Robert; Decaens, Thomas; Kudo, Masatoshi et al.
Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW.JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 17_SUPPL. 2024 S. LBA4008-LBA4008
Dreismickenbecker, Elias; Fleckenstein, Johannes; Walter, Carmen et al.
Nociceptive Processing of Elite Athletes Varies between Sport-Specific Loads: An EEG-Based Study ApproachMEDICINE & SCIENCE IN SPORTS & EXERCISE. Bd. 56. H. 6. 2024 S. 1046-1055
Ruemmler, Robert; Iwobi, Naomi; Simpfendoerfer, Viktoria et al.
Nociceptive Profiles During Awake Craniotomies Using Non-Invasive Nociception Level MonitoringANESTHESIA AND ANALGESIA. Bd. 139. H. 6. 2024 S. 1765-1766